Position in ABT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$12,088,468
-$4,335,798 QoQ
Shares Held
117,741
-10.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $29,066,889 across 61 Medical Devices names. ABT ranks #1 (41.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
117,741 | $12,088,468 | |
| 2 | SYK |
Stryker Corp
|
22,738 | $7,471,479 | |
| 3 | EW |
Edwards Lifesciences Corp
|
49,434 | $3,958,674 | |
| 4 | MDT |
Medtronic plc
|
24,856 | $2,153,772 | |
| 5 | BSX |
Boston Scientific Corp
|
14,348 | $900,337 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
7,904 | $562,606 | |
| 7 | STE |
STERIS plc
|
878 | $194,152 | |
| 8 | DXCM |
Dexcom Inc
|
2,861 | $179,670 |
All Filings in ABT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,088,468 | 117,741 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $16,424,266 | 131,090 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $17,232,452 | 128,658 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,647,297 | 129,750 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $16,918,181 | 127,540 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $14,237,042 | 125,869 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $13,832,263 | 121,325 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,684,189 | 122,069 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $13,679,208 | 120,352 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $12,911,100 | 117,299 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,513,721 | 118,882 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $13,059,178 | 119,787 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $11,990,601 | 118,414 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $3,579,483 | 32,603 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $3,217,560 | 33,253 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,425,951 | 31,532 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,371,366 | 28,484 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $4,536,613 | 32,234 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,649,271 | 30,892 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $3,023,454 | 26,080 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,294,761 | 27,493 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,637,833 | 24,092 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,622,150 | 24,094 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,804,919 | 19,741 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $1,716,371 | 21,751 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||